Cargando…
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
INTRODUCTION: Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity. It is histologically characterized by a marked dilatation of the glomerular capillaries and the presence of lipopro...
Autores principales: | Russi, Gianpaolo, Furci, Luciana, Leonelli, Marco, Magistroni, Riccardo, Romano, Nicola, Rivasi, Paolo, Albertazzi, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803834/ https://www.ncbi.nlm.nih.gov/pubmed/20062740 http://dx.doi.org/10.1186/1752-1947-3-9311 |
Ejemplares similares
-
Lipoprotein Glomerulopathy Associated with a Mutation in Apolipoprotein E
por: Magistroni, Riccardo, et al.
Publicado: (2013) -
Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience)
por: Kolovou, Genovefa, et al.
Publicado: (2012) -
The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19
por: Jaeger, Beate Roxane, et al.
Publicado: (2022) -
Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019) -
Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)